Loading...
Pharma Equity Group
powered by Stokk.io

Capital Increase: How, Why & Next Step

Wed, 23 Oct, 2024, 14:00 – 14:30
This event has ended. Sign up below to watch the recording.
Sign in to access all the features of the platform.

How does this Q&A work:

This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.

The company will address as many questions as possible, and focus on those questions most wanted by investors.

Speakers at this event:

Thomas Kaas Selsø
CEO

9 Questions

A
A**** *****
Oct. 23, 2024

Can you put some words to the news today about the japanese patent?

A
A**** *****
Oct. 22, 2024

What key milestones do you expect to achieve within the next 12 months, and how will these impact your prospects for future funding?

A
A**** *****
Oct. 22, 2024

Do you have a strategy to find additional funding paths that do not dilute shareholders such as grants or likewise?

S
S**** *****
Oct. 22, 2024

When should investors expect to see you land the first licensing partner?

S
S**** *****
Oct. 22, 2024

How is the work with licensing partners progressing?

S
S**** *****
Oct. 22, 2024

What will you do to attract larger investors to the company?

S
S**** *****
Oct. 22, 2024

Now you have created a much more robust capital structure with increased equity and more than 75% reduced debt. But how will you ensure long-term financing?

A
A**** *****
Oct. 22, 2024

There will be a dilution of approximately 17% for existing shareholders. What does this mean in practice for an investor, and is the investor negatively affected by a capital increase at market price?

V
V**** *****
Oct. 22, 2024

Why are you conducting a capital increase, and how does it relate to the fact that you first made a capital reduction and then a capital increase?